Itoh H | Department Of Pathology & Division Of Diagnostic Pathology Tokai University School Of Medicine
スポンサーリンク
概要
- ITOH Hitoshiの詳細を見る
- 同名の論文著者
- Department Of Pathology & Division Of Diagnostic Pathology Tokai University School Of Medicineの論文著者
関連著者
-
Itoh H
Department Of Pathology & Division Of Diagnostic Pathology Tokai University School Of Medicine
-
Umemura Shinobu
Department Of Pathology & Division Of Diagnostic Pathology Tokai University School Of Medicine
-
Osamura R.
Department Of Pathology School Of Medicine Tokai University
-
UMEMURA Shinobu
Cytology and Core Needle Biopsy Subcommittee of the Japanese Breast Cancer Society
-
ITOH Hitoshi
Department of Pathology, Tokai University School of Medicine
-
Umemura S
Department Of Pathology Tokai University School Of Medicine
-
Itoh Hitoshi
Department Of Pathology School Of Medicine Tokai University
-
Umemura S
Tokai Univ. School Of Medicine
-
Osamura R.
Department of Pathology, School of Medicine, Tokai University
-
ITOH HITOSHI
Department of Neuropsychiatry, School of Medicine, Keio University
-
Sekido Yasutomo
Department Of Pathology Shizuoka Medical Center
-
Osamura R.yoshiyuki
Department Of Pathology & Division Of Diagnostic Pathology Tokai University School Of Medicine
-
Kato Nobuaki
Division Of Diagnostic Pathology Tokai University Hospital
-
Itoh Hitoshi
Division Of Diagnostic Pathology Tokai University Hospital
-
Hatanaka Yutaka
Department Of Pathology School Of Medicine Tokai University
-
Hatanaka Yutaka
Department Of Biochemistry Osaka University Medical School
-
Serizawa Akihiko
Division Of Diagnostic Pathology Tokai University Hospital
-
Sekido Y
Department Of Pathology Tokai University School Of Medicine
-
ITOH Hitoshi
Department of Nuclear Engineering, Kyushu University
著作論文
- Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH)
- THERAPEUTIC APPLICATION OF HISTOCHEMISTRY TO BREAST CANCERS : Trastuzumab treatment and selection of patients based on HER2 histochemistry
- Pathological Evaluation of HER2 Overexpression : For the Treatment of Metastatic Breast Cancers by Humanized Anti-HER2 Monoclonal Antibody (Trastuzumab)